The Virtual CVOT Summit 2024 will start on 5 December at 15:30 CET.The livestream will start today at 15:30 CET.Welcome and Introduction15:30 – 15:40 CETOliver Schnell (Munich, Germany)Update on the treatment of heart failure - new approaches, new outcomes15:40 – 15:55 Mikhail Kosiborod (Kansas City, US)Chronic kidney disease: Cornerstones of today´s treatment and opportunities for the future15:55 – 16:10 Beatriz Fernández-Fernández (Madrid, Spain)The next decade in the treatment of obesity16:10 - 16:25Barbara McGowan (London, UK)Organ Cross-Talk and Person-Centered Management of Obesity, CKD, Lipid Disorders, and Diabetes16:25 - 16:45Dirk Müller-Wieland (Aachen, Germany)Microplastics and nanoplastics (MNPs): An emerging risk factor for cardiovascular disease16:45 - 17:00Antonio Ceriello (Milan, Italy)Panel Discussion17:00 – 17:15Break17:15 – 17:30 CETThe Taskforce of the Guideline Workshop: Aims and outcomes17:30 – 17:45 Oliver Schnell (Munich, Germany)Towards standardization of patient reported outcomes (PROs)17:45 – 18:00Katharine Barnard-Kelly (Hampshire, UK)Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases18:00 – 18:15James R. Gavin (Atlanta, USA)Network meta-analyses and clinical guidelines: what is missing for a precision medicine approach 18:15 – 18:30Francesco Giorgino (Bari, Italy)Discussion18:30 – 18:45Break18:45 – 19:00 CETWelcome and introduction 19:00 – 19:03Sarah Jarvis (London, UK)Why does connecting the dots matter in CRM diseases?19:03 - 19:13Nikolaus Marx (Aachen, Germany)Connecting the dots in CRM disease: how do we work together?19:13 – 19:23Sarah Jarvis (London, UK)Connecting the dots in understanding CRM disease: does aldosterone have a role?19:23 – 19:33Per-Henrik Groop (Helsinki, Finland)Panel discussion: Connecting the dots in multidisciplinary care19:33 - 19:58Closing remarks/final thoughts19:58 - 20:00Sarah Jarvis (London, UK)OP 1: Micro- and Macroangiopathy Related to Diabetes: Beyond HbA1c, Should We Rely on New Glucose Metrics?Bruno Guerci (Nancy, France)OP 2: The Impairment of Myocardial Structure in Patients with Type 2 Diabetes Mellitus without Cardiovascular DiseaseIvanna Zubovych (Kyiv, Ukraine)OP 3: Characterizing the Healthcare Resource Use and Costs for Patients Aged 65-89 Years with Laboratory Evidence of CKD With and Without a Recorded DiagnosisJieling Chen (Gaithersburg, USA)OP 4: Improvement of Health-Related Quality of Life after Bariatric Surgery in Patients with Severe Obesity and Type 2 DiabetesTamar Shervashidze (Tbilisi, Georgia)Closing of Day 120:45 CETOliver Schnell (Munich, Germany)The Virtual CVOT Summit 2024 continues tomorrow, Friday, 6 December, at 08:30 CET. We look forward to your participation!The Virtual CVOT Summit 2024 continues tomorrow, Friday, 6 December, at 08:30 CET. We look forward to your participation!The livestream will start today at 08:30 CET.Early detection of Type 1 Diabetes - risk evaluation, markers and early diagnosis programs08:30 – 08:45Thomas Danne (Lisbon, Portugal)Treatment strategies for delaying the onset of Type 1 Diabetes08:45 – 09:00Colin M. Dayan (Cardiff, UK)Future directions in the treatment of CKD in Type 1 Diabetes 09:00 – 09:15 Hiddo Heerspink (Groningen, Netherlands)Discussion09:15 – 09:30Continuous glucose monitoring in Type 2 Diabetes09:30 – 09:45 Stefano del Prato (Pisa, Italy)CGM and cardiovascular perspectives09:45 – 10:00Ulf Landmesser (Berlin, Germany)CGM, hypoglycemia and risk prediction10:00 – 10:15Lutz Heinemann (San Diego, US)Automated Insulin delivery (AID), physical activity and exercise in Type 1 Diabetes10:15 – 10:30Othmar Moser (Bayreuth, Germany)Discussion10:30 - 10:45Break10:45 – 11:00 CETUACR and eGFR: barriers of implementation 11:00 - 11:15Elke Schäffner (Berlin, Germany)KDIGO guidelines 2024: consistence with ESC?11:15 – 11:30Michel Jadoul (Brussels, Belgium)REVOLUTIONizing heart failure diagnosis11:30 – 11:45Lisa Anderson (London, UK)Discussion11:45 - 12:00Cardiac autonomic neuropathy: current experimental and clinical practice considerations12:00 – 12:10Alin Stirban (Birkenwerder, Germany)Mitochondrial metabolomics and the diabetic heart12:10 – 12:20 Eberhard Standl (Munich, Germany)Discussion12:20 – 12:30Cardiovascular Risk evaluation in primary care12:30 – 12:45Naresh Kanumilli (Manchester, UK)Interconnectedness of Heart, Kidney and Metabolism – Perspectives of PCPs12:45 - 13:00Xavier Cos (Barcelona, Spain)Empowering diabetes self-management: the path to success13:00 - 13:15Tatjana Milenkovic (Skopje, Macedonia)Discussion13:15 – 13:30Break13:30 - 14:00 CETObesity as a therapeutic target in heart failure therapy14:00 – 14:15Luc van Gaal (Antwerp, Belgium)GIP/GLP-1 receptor agonists – a new dawn in sleep apnea therapy?14:15 – 14:30 Igor Harsch (Saalfeld, Germany)Discussion14:30 - 14:45On the Path to Precision Nutrition in Cardiometabolic Diseases14:45 - 15:00Andreas Pfeiffer (Potsdam, Germany)Navigating Nutrition under Incretin-Based Therapies15:00 - 15:15Jaime Almandoz (Texas, USA)Discussion15:15 - 15:30Diagnosis and Treatment of MASLD: Current State of the Art15:30 - 15:45Wendy Spearman (Cape Town, South Africa)The liver – a new target for incretin therapies?15:45 - 16:00 Frank Tacke (Berlin, Germany)Discussion16:00 - 16:15Break16:15 - 16:30 CETIndustry’s perspective - Panel Discussion16:30 - 17:30 CETOliver Schnell (Munich, Germany)OP 5: Aldosterone Synthase Inhibitor Vicadrostat (BI 690517) ± Empagliflozin in a CKD Phase II Trial: Effects on Albuminuria and SBP in Patients with/without T2DPeter Rossing (Copenhagen, Denmark)OP 6: Endothelial Dysfunction and Cardiovascular Pathology in Patients with Metabolic Dysfunction-Associated Steatotic Liver DiseaseKateryna Pivtorak (Vinnytsia, Ukraine)OP 7: Consistency in Glucose Monitoring, Consistency in Care: Standardizing CGM Evaluation for Better Patient OutcomesGuido Freckmann (Ulm, Germany)OP 8: Age is No Barrier to Diabetes Technology: Improvements in Glycemia in Older People with Type 2 Diabetes Mirror Engagement Levels with the OneTouch Reveal® Mobile Diabetes Management AppElizabeth Holt (Malvern, PA, USA)Abstract Award and Closing18:15 – 18:30 CET Oliver Schnell (Munich, Germany) Thank you for your attendance and contribution to the Virtual CVOT Summit 2024. See you next year for the 11th CVOT Summit on 20 - 21 November 2025.Thank you for your attendance and contribution to the Virtual CVOT Summit 2024. See you next year for the 11th CVOT Summit on 20 - 21 November 2025. We will be right back.We are currently having some technical issues. We will be right back.The page is automatically updated.The next program item is loaded.
